会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • THIOPHENE COMPOUNDS
    • 噻吩化合物
    • WO2013016490A1
    • 2013-01-31
    • PCT/US2012/048258
    • 2012-07-26
    • VERTEX PHARMACEUTICALS INCORPORATEDLUISI, BrianWILLCOX, DavidROEPER, StefanieHU, Kan-NianLUONG, Hoa, Q.
    • LUISI, BrianWILLCOX, DavidROEPER, StefanieHU, Kan-NianLUONG, Hoa, Q.
    • C07D333/40A61K31/381A61P31/14
    • C07D333/40A61K9/0019A61K9/1652A61K9/2054A61K9/2077A61K9/4858A61K9/4866A61K31/381A61K47/40C07D333/38
    • Polymorph Forms M, H, P, X, and ZA of Compound (1) represented by the following structural formula: are described. A method of preparing polymorph Form M of Compound (1) includes stirring a mixture of Compound (1) and a solvent system that includes isopropanol, ethyl acetate, n -butyl acetate, methyl acetate, acetone, 2-butanone (methylethylketone (MEK)), or heptane, or a combination thereof at a temperature in a range of 10 °C to 47 °C to form From M of Compound (1). A method of preparing polymorph Form H of Compound (1) includes stirring a solution of Compound (1) at a temperature in a range of 48 °C to 70 °C to form Form H of Compound (1). A method of preparing polymorph Form P of Compound (1) includes stirring a mixture of Compound (1) and a solvent system that includes a solvent selected from the group consisting of dichloromethane and tetrahydrofuran (THF), and a mixture thereof at room temperature to form Form P of Compound (1). A method of preparing polymorph Form X of Compound (1) includes removing ethyl acetate from ethylacetate solvate G of Compound (1). A method of preparing polymorph Form ZA of Compound (1) includes removing n -butyl acetate from n-butyl acetate solvate A of Compound (1).
    • 描述了由以下结构式表示的化合物(1)的多晶型:M,H,P,X和ZA。 制备化合物(1)的多晶型物M的方法包括搅拌化合物(1)和包括异丙醇,乙酸乙酯,乙酸正丁酯,乙酸甲酯,丙酮,2-丁酮(甲基乙基酮(MEK))的溶剂体系的混合物, )或庚烷或其组合,在10℃至47℃的温度范围内,以形成化合物(1)的M。 制备化合物(1)的多晶型物H的方法包括在48℃至70℃的温度范围内搅拌化合物(1)的溶液以形成化合物(1)的H型。 制备化合物(1)的多晶型P的方法包括:将化合物(1)和包含选自二氯甲烷和四氢呋喃(THF)的溶剂的溶剂体系的混合物及其混合物在室温下搅拌至 形成化合物(1)的形式P. 制备化合物(1)的多晶型物X的方法包括从化合物(1)的乙酸乙酯溶剂化物G中除去乙酸乙酯。 制备化合物(1)的多晶型ZA的方法包括从化合物(1)的乙酸正丁酯溶剂化物A中除去乙酸正丁酯。
    • 7. 发明公开
    • THIOPHENE COMPOUNDS
    • 噻吩化合物
    • EP2736893A1
    • 2014-06-04
    • EP12743039.5
    • 2012-07-26
    • Vertex Pharmaceuticals Incorporated
    • LUISI, BrianWILLCOX, DavidROEPER, StefanieHU, Kan-NianLUONG, Hoa, Q.
    • C07D333/40A61K31/381A61P31/14
    • C07D333/40A61K9/0019A61K9/1652A61K9/2054A61K9/2077A61K9/4858A61K9/4866A61K31/381A61K47/40C07D333/38
    • Polymorph Forms M, H, P, X, and ZA of Compound (1) represented by the following structural formula: are described. A method of preparing polymorph Form M of Compound (1) includes stirring a mixture of Compound (1) and a solvent system that includes isopropanol, ethyl acetate,
      n -butyl acetate, methyl acetate, acetone, 2-butanone (methylethylketone (MEK)), or heptane, or a combination thereof at a temperature in a range of 10 °C to 47 °C to form From M of Compound (1). A method of preparing polymorph Form H of Compound (1) includes stirring a solution of Compound (1) at a temperature in a range of 48 °C to 70 °C to form Form H of Compound (1). A method of preparing polymorph Form P of Compound (1) includes stirring a mixture of Compound (1) and a solvent system that includes a solvent selected from the group consisting of dichloromethane and tetrahydrofuran (THF), and a mixture thereof at room temperature to form Form P of Compound (1). A method of preparing polymorph Form X of Compound (1) includes removing ethyl acetate from ethylacetate solvate G of Compound (1). A method of preparing polymorph Form ZA of Compound (1) includes removing
      n -butyl acetate from n-butyl acetate solvate A of Compound (1).
    • 描述了由以下结构式表示的化合物(1)的多晶型物M,H,P,X和ZA: 制备化合物(1)的多晶型形式M的方法包括搅拌化合物(1)和包括异丙醇,乙酸乙酯,乙酸正丁酯,乙酸甲酯,丙酮,2-丁酮(甲乙酮(MEK))的溶剂体系的混合物。 )或庚烷或其组合在10℃至47℃范围内的温度下从化合物(1)形成M. 制备化合物(1)的多晶型形式H的方法包括在48℃至70℃的温度范围内搅拌化合物(1)的溶液以形成化合物(1)的形式H. 制备化合物(1)的多晶型形式P的方法包括在室温下将化合物(1)和包含选自二氯甲烷和四氢呋喃(THF)的溶剂的溶剂体系的混合物及其混合物在室温下搅拌至 形成化合物(1)的形式P. 制备化合物(1)的多晶型形式X的方法包括从化合物(1)的乙酸乙酯溶剂合物G中除去乙酸乙酯。 制备化合物(1)的多晶型物ZA的方法包括从化合物(1)的乙酸正丁酯溶剂化物A中除去乙酸正丁酯。